VR Logo

Unrated

IDBI Healthcare Fund - Direct Plan


1 Lakh

Investment Grown to
₹ 1.33 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.40 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 20.16 0.58 -1.05 4.58 8.16 26.29 32.65 -- -- -- --
S&P BSE Healthcare TRI 23.23 0.70 -1.00 4.33 7.18 27.60 37.94 -- -- -- --
Equity: Sectoral-Pharma 22.39 0.70 -0.85 4.15 8.36 26.91 38.44 -- -- -- --
Rank within category 9 9 7 4 6 7 9 -- -- -- --
Number of funds in category 10 10 10 10 10 10 9 6 4 3 0

As on 23-Sep-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
IDBI Healthcare Fund - Direct Plan
Unrated
Feb-19 32.65 -- -- 1.24 84
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 42.38 25.97 17.52 1.14 5,667
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 36.72 27.44 -- 1.15 3,158
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 38.29 23.31 11.07 1.05 2,048
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 43.30 32.06 -- 0.56 1,901

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 21.62 01-Apr-2020 - 09-Apr-2020 -10.96 05-Mar-2020 - 12-Mar-2020
Month 34.89 23-Mar-2020 - 22-Apr-2020 -19.31 20-Feb-2020 - 23-Mar-2020
Quarter 43.94 23-Mar-2020 - 22-Jun-2020 -11.82 23-Dec-2019 - 23-Mar-2020
Year 75.21 23-Mar-2020 - 23-Mar-2021 -6.28 22-Mar-2019 - 23-Mar-2020

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 20.04 21.96 0.73 1.60 -- --
Equity: Sectoral-Pharma* 25.01 19.99 1.05 2.36 0.89 6.71
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Aug-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 29
Top 10 Stocks (%) 62.71
Top 5 Stocks (%) 45.26
Top 3 Sectors (%) 93.14
Portfolio P/B Ratio 5.38
Portfolio P/E Ratio 33.49

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 56,934 58,801
Giant (%) 15.71 15.06
Large (%) 47.02 45.41
Mid (%) 32.48 32.94
Small (%) 4.80 8.56
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Industries Healthcare 30.90 12.79 0.00 12.14
equal Divi's Laboratories Healthcare 67.22 10.82 0.00 10.82
equal Dr. Reddy's Lab Healthcare 46.00 12.06 0.00 8.40
equal Cipla Healthcare 31.20 8.40 0.00 7.48
equal Apollo Hospitals Healthcare 468.96 6.42 0.00 6.42
equal Aurobindo Pharma Healthcare 8.02 6.61 0.00 4.17
equal Ipca Laboratories Healthcare 31.00 6.88 0.00 3.71
equal Lupin Healthcare 25.73 6.19 0.00 3.61
equal Gland Pharma Healthcare 64.25 3.12 0.00 3.03
equal JB Chemicals & Pharma Healthcare 30.95 3.19 0.00 2.93
equal Alkem Laboratories Healthcare 29.44 4.43 0.00 2.90
equal Torrent Pharmaceuticals Healthcare 41.57 3.69 0.00 2.78
equal Laurus Labs Healthcare 31.25 3.83 0.00 2.72
equal Abbott India Healthcare 64.72 4.21 0.00 2.09
equal Indoco Remedies Healthcare 36.13 1.96 0.00 1.96
equal Syngene International Healthcare 61.74 2.80 0.00 1.95
equal Jubilant Ingrevia Healthcare 225.37 1.85 0.00 1.85
new Tata Steel Metals 7.49 1.72 0.00 1.72
equal Pfizer Healthcare 46.40 4.05 0.00 1.72
equal Rossari Biotech Chemicals 91.09 1.71 0.00 1.67
equal Cadila Healthcare Healthcare 25.50 2.30 0.00 1.65
equal Vinati Organics Chemicals 69.07 1.56 0.00 1.39
equal Biocon Healthcare 64.67 2.66 0.00 1.28
equal Aster DM Healthcare Healthcare 38.34 1.26 0.00 1.25
equal Metropolis Healthcare Healthcare 62.17 1.20 0.00 1.13

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Aug-2021

Fund Manager

— Alok Ranjan since 06-Aug-2021

Education: Mr. Ranjan has done MBA (Finance), BSc Physics (Honors)

Experience: Prior to joining IDBI Asset Management Limited he was associated with Shriram Asset Management Ltd. as Fund Manager (Equity), Way2wealth Securities Ltd. as Head of Research and Advisory and First Global Ltd. as Vice President- Research.

Funds Managed:


0.58%

Change from previous, NAV as on 23-Sep-2021

Growth: ₹ 20.8000

IDCW: ₹ 20.8000


Investment Strategy

The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 1,000
Minimum Balance (₹) 1
Lock-in Period Not Applicable
Exit Load 1% for redemption within 365 days

Basic Details

Fund House: IDBI Mutual Fund
Launch Date: 28-Feb-2019
Return Since Launch: 32.97%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 84 Cr (As on 31-Aug-2021)
Expense: 1.24% (As on 31-Aug-2021)
Risk Grade: --
Return Grade: --
Turnover: 67.00%

Contact Information

AMC: IDBI Asset Management Ltd.

Address: 4th Floor, IDBI Tower, WTC Complex, Cuffe Parade, Colaba, Mumbai - 400005

Phone: 022-66442800 / 1800-419-4324

Fax: 022-66442801

Email: [email protected]

Website: http://www.idbimutual.co.in

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Viewpoint

The Case for ESG Investing

DateThursday, 30-Sep-2021
Time04:00 PM - 04:30 PM